Europe Microbial Air Sampler Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Europe Microbial Air Sampler Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Europe Microbial Air Sampler Market Segmentation, By Product (Portable microbial air sampler, Desktop microbial air sampler, and accessories), Collection technique (Impact air sampler, impinge air sampler, surface air sampler, compressed air sampler, real-time samplers, and others), End User (Research & Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Food & beverage, Personal care industries, and others), Distribution Channel (Direct tender, Retail sales, Third Party distributor, and others)- Industry Trends and Forecast to 2033

  • Healthcare
  • Jul 2021
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Author : Sachin Pawar

Europe Microbial Air Sampler Market

Market Size in USD Million

CAGR :  % Diagram

Bar chart comparing the Europe Microbial Air Sampler Market size in 2025 - 115.59 and 2033 - 233.72, highlighting the projected market growth. USD 115.59 Million USD 233.72 Million 2025 2033
Diagram Forecast Period
2026 –2033
Diagram Market Size (Base Year)
USD 115.59 Million
Diagram Market Size (Forecast Year)
USD 233.72 Million
Diagram CAGR
%
Diagram Major Markets Players
  • MBV AG
  • Sartorius AG
  • BIOMÉRIEUX
  • Merck Millipore
  • TSI

Europe Microbial Air Sampler Marketz

Europe Microbial Air Sampler Market Size

  • The Europe microbial air sampler market size was valued at USD 115.59 million in 2025 and is expected to reach USD 233.72 million by 2033, at a CAGR of 9.2% during the forecast period
  • The market growth is largely driven by stringent regulatory standards across the EU for contamination control in pharmaceuticals, food & beverage, and healthcare sectors, coupled with the rising adoption of advanced air quality monitoring technologies to ensure clean environments in production and research facilities
  • Furthermore, increasing awareness about occupational safety, infection control requirements in clinical and cleanroom settings, and the continual expansion of pharmaceutical and biotech R&D activities are boosting demand for microbial air samplers as critical tools for environmental monitoring. These factors are accelerating the adoption of microbial air sampling solutions, thereby significantly fueling the industry’s growth

Europe Microbial Air Sampler Market Analysis

  • Microbial air samplers, used for monitoring airborne microorganisms in cleanrooms, laboratories, and controlled environments, are increasingly essential in pharmaceutical, healthcare, food & beverage, and biotechnology sectors to ensure contamination-free environments and compliance with stringent regulatory standards
  • The growing demand for microbial air samplers is primarily driven by strict EU regulations for environmental monitoring, rising awareness of occupational safety, and the need for reliable contamination control in critical production and research processes
  • Germany dominated the Europe microbial air sampler market with the largest revenue share of 38.5% in 2025, attributed to its strong pharmaceutical and biotech industries, high adoption of advanced environmental monitoring technologies, and well-established regulatory framework for cleanroom standards
  • The U.K. is expected to be the fastest-growing country during the forecast period due to the expansion of pharmaceutical R&D activities, increasing investment in healthcare infrastructure, and growing adoption of advanced cleanroom monitoring solutions
  • Portable microbial air sampler segment dominated the market with the largest market share of 45.7% in 2025, driven by their ease of use, flexibility across multiple locations, and suitability for on-demand monitoring in laboratories, hospitals, and food production facilities

Report Scope and Europe Microbial Air Sampler Market Segmentation       

Attributes

Europe Microbial Air Sampler Key Market Insights

Segments Covered

  • By Product: Portable microbial air sampler, Desktop microbial air sampler, and accessories
  • By Collection technique: Impact air sampler, impinge air sampler, surface air sampler, compressed air sampler, real-time samplers, and others
  • By End User: Research & Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Food & beverage, Personal care industries, and others
  • By Distribution Channel: Direct tender, Retail sales, Third Party distributor, and others

Countries Covered

Europe

  • Germany
  • France
  • U.K.
  • Netherlands
  • Switzerland
  • Belgium
  • Russia
  • Italy
  • Spain
  • Turkey
  • Rest of Europe

Key Market Players

  • MBV AG (Switzerland)
  • Sartorius AG (Germany)
  • BIOMÉRIEUX (France)
  • Merck Millipore (Germany)
  • TSI (U.S.)
  • Climet Instruments Company (U.S.)
  • VWR International, LLC (U.S.)
  • Particle Measuring Systems (U.S.)
  • Bioscience International (U.S.)
  • Aquaria srl (Italy)
  • IUL, S.A. (Spain)
  • MBV (Switzerland)
  • Munro Instruments Limited (U.K.)
  • Cherwell Laboratories (U.K.)
  • Cantium Scientific Limited (U.K.)
  • Orum International Srl (Italy)
  • Awel (France)
  • Sarstedt AG & Co. KG (Germany)
  • Bertin Technologies (France)
  • Advanced Instruments (U.S.)

Market Opportunities

  • Rising demand for real-time airborne pathogen detection in hospitals
  • Growth in the biopharmaceutical sector

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Europe Microbial Air Sampler Market Trends

Automation and Real-Time Monitoring Integration

  • A significant and accelerating trend in the Europe microbial air sampler market is the increasing integration with automated sampling systems and real-time monitoring platforms, enabling continuous tracking of airborne microorganisms in critical environments
    • For instance, the Sartorius MD8 Airscan can integrate with automated laboratory systems to provide continuous monitoring and data logging without manual intervention, enhancing operational efficiency
  • Integration with digital dashboards and IoT-enabled devices allows facilities to receive real-time alerts, generate compliance reports, and optimize cleaning protocols based on collected microbial data, significantly reducing contamination risks
  • The seamless incorporation of microbial air samplers with environmental control systems in cleanrooms and laboratories allows centralized management of multiple monitoring points, facilitating coordinated responses to contamination events
  • This trend towards more intelligent, automated, and connected microbial monitoring systems is reshaping operational practices in pharmaceutical, biotech, and healthcare facilities. Consequently, companies such as Merck are developing IoT-enabled air samplers with automated sampling schedules, data analytics, and remote monitoring capabilities
  • The demand for microbial air samplers with advanced automation and real-time monitoring is increasing rapidly across pharmaceutical, clinical, and food production facilities as regulatory compliance and contamination prevention become critical priorities
  • Integration with predictive analytics software is emerging, allowing facilities to forecast microbial load trends and optimize preventive measures, reducing downtime and enhancing operational safety

Europe Microbial Air Sampler Market Dynamics

Driver

Strict Regulatory Compliance and Contamination Control Requirements

  • The stringent EU regulations on cleanroom standards, GMP compliance, and contamination control are a major driver for the adoption of microbial air samplers
    • For instance, in March 2025, TSI Inc. launched a new real-time air monitoring solution for pharmaceutical cleanrooms, designed to meet ISO 14644 standards and optimize microbial surveillance workflows
  • As companies aim to comply with hygiene standards and avoid costly product recalls, microbial air samplers provide reliable detection of airborne microorganisms and facilitate timely corrective measures
  • Rising awareness of occupational safety and infection control in laboratories, hospitals, and food manufacturing units further propels market demand for precise environmental monitoring solutions
  • The convenience of automated sampling, remote data access, and integration with laboratory information management systems (LIMS) is encouraging broader adoption of microbial air samplers across pharmaceutical, biotech, and food production sectors
    • For instance, some European hospitals have implemented networked air samplers to monitor multiple wards simultaneously, enabling centralized control and rapid response to contamination events
  • Increasing investment in R&D facilities and expansion of pharmaceutical production capacities across Europe is creating sustained demand for advanced microbial air samplers to ensure regulatory compliance and product safety

Restraint/Challenge

High Initial Costs and Calibration Complexity

  • The relatively high initial investment required for advanced microbial air samplers poses a barrier to adoption, particularly for smaller laboratories or developing country facilities
    • For instance, sophisticated samplers from companies such as Merck and Sartorius can cost significantly more than basic units, discouraging purchase by budget-conscious operations
  • Ensuring precise calibration and maintenance of microbial air samplers requires skilled personnel and periodic servicing, which adds operational complexity and costs
  • The complexity of integrating real-time monitoring systems with existing laboratory or cleanroom infrastructure can delay adoption and require additional IT and technical support
  • Overcoming these challenges through cost-effective product offerings, simplified calibration procedures, and training programs for facility personnel will be crucial for sustained growth of the microbial air sampler market in Europe
    • For instance, facilities with limited technical expertise may struggle to operate advanced samplers efficiently, leading to potential data inaccuracies and decreased reliability of monitoring results
  • Variability in national regulations across European countries can pose compliance challenges for manufacturers and end-users, requiring additional documentation, testing, and alignment with local standards

Europe Microbial Air Sampler Market Scope

The market is segmented on the basis of product, collection technique, end user, and distribution channel.

  • By Product

On the basis of product, the Europe microbial air sampler market is segmented into portable microbial air samplers, desktop microbial air samplers, and accessories. The portable microbial air sampler segment dominated the market with the largest revenue share of 45.7% in 2025, driven by its versatility, ease of transport, and suitability for on-demand monitoring across multiple locations. Portable samplers are particularly favored in hospitals, research labs, and food processing facilities where flexibility and rapid deployment are critical. Their compact design and straightforward operation allow technicians to conduct environmental monitoring with minimal setup time. In addition, regulatory compliance requirements in pharmaceuticals and biotech labs create strong demand for reliable, portable sampling devices. Portable samplers also offer compatibility with advanced data logging systems, enabling seamless reporting and trend analysis.

The desktop microbial air sampler segment is anticipated to witness the fastest growth rate of 19.8% from 2026 to 2033, fueled by increasing adoption in pharmaceutical manufacturing and academic research institutes. Desktop samplers provide higher throughput, greater precision, and integration with laboratory software systems, making them ideal for permanent installations in cleanrooms and controlled laboratories. The ability to handle multiple samples simultaneously and ensure consistent collection volumes drives their preference among high-volume users. Desktop units are also benefiting from advancements in real-time microbial detection and automated analysis features, which reduce labor requirements and improve data reliability.

  • By Collection Technique

On the basis of collection technique, the market is segmented into impact air samplers, impinge air samplers, surface air samplers, compressed air samplers, real-time samplers, and others. The impact air sampler segment dominated the market in 2025, owing to its widespread use in pharmaceuticals, hospitals, and cleanrooms due to proven efficiency in capturing viable microorganisms from air samples. Impact samplers are valued for their high reproducibility, ability to process large volumes of air quickly, and compatibility with standard culture media. Facilities prefer impact samplers for compliance with ISO 14644 standards and routine environmental monitoring schedules. Their robust design and ease of maintenance further strengthen their market position. In addition, impact samplers can be integrated with automated sampling systems for large-scale monitoring programs.

The real-time sampler segment is expected to witness the fastest CAGR from 2026 to 2033, driven by increasing demand for continuous monitoring and immediate contamination alerts. Real-time samplers allow facilities to detect microbial loads instantaneously and implement corrective actions promptly, reducing downtime and minimizing risk of contamination. They are increasingly adopted in pharmaceutical R&D, hospitals, and food production facilities where instant feedback is critical. Integration with IoT platforms and cloud-based data management systems enhances their appeal, enabling remote monitoring and compliance reporting. The ability to predict trends and optimize cleaning schedules makes real-time samplers a rapidly growing subsegment.

  • By End User

On the basis of end user, the Europe microbial air sampler market is segmented into research and academic institutes, hospitals and clinics, pharmaceutical and biotechnology companies, food and beverage, personal care industries, and others. The pharmaceutical and biotechnology companies segment dominated the market in 2025, due to stringent regulatory requirements for cleanroom monitoring, GMP compliance, and contamination prevention in drug production and research. These companies require precise, reliable microbial air sampling to avoid costly product recalls and ensure patient safety. The adoption of advanced samplers with automated data logging and reporting systems further strengthens their dominance. Large-scale production facilities, contract research organizations (CROs), and biotechnology R&D centers continue to drive consistent demand for high-quality microbial air samplers.

The hospitals and clinics segment is anticipated to witness the fastest growth rate of 18.5% from 2026 to 2033, driven by increasing infection control awareness, particularly in surgical suites, ICUs, and patient care areas. Hospitals are adopting portable and real-time samplers to monitor airborne microorganisms and prevent hospital-acquired infections. Growing regulatory focus on patient safety and the need to maintain sterile environments for immunocompromised patients further accelerates adoption. Integration with hospital environmental monitoring systems enables centralized oversight and rapid response, increasing operational efficiency and compliance with hygiene standards.

  • By Distribution Channel

On the basis of distribution channel, the Europe microbial air sampler market is segmented into direct tender, retail sales, third-party distributor, and others. The direct tender segment dominated the market in 2025, as large pharmaceutical companies, hospitals, and research institutions prefer purchasing samplers directly from manufacturers to ensure quality, after-sales support, and compliance with procurement regulations. Direct tendering allows for customization, bulk orders, and long-term service contracts, making it the preferred channel for high-value equipment. Manufacturers often provide on-site installation, calibration, and training, strengthening this channel’s dominance. In addition, direct contracts simplify regulatory documentation and certification processes, which are critical in regulated sectors such as pharma and biotechnology.

The third-party distributor segment is expected to witness the fastest CAGR from 2026 to 2033, driven by the growing presence of distributors offering a wide range of products, flexible payment options, and regional support in countries with emerging pharmaceutical and healthcare infrastructure. Third-party distribution networks facilitate faster market penetration, especially for SMEs and mid-sized hospitals that may lack direct procurement agreements with manufacturers. Distributors also offer bundled packages, including consumables and maintenance services, which increases their appeal to end-users seeking cost-effective and convenient solutions.

Europe Microbial Air Sampler Market Regional Analysis

  • Germany dominated the Europe microbial air sampler market with the largest revenue share of 38.5% in 2025, attributed to its strong pharmaceutical and biotech industries, high adoption of advanced environmental monitoring technologies, and well-established regulatory framework for cleanroom standards
  • Laboratories, hospitals, and manufacturing facilities in the region prioritize accurate and reliable air sampling to comply with ISO 14644 and GMP standards, ensuring product quality, patient safety, and contamination control
  • This widespread adoption is further supported by advanced laboratory infrastructure, high investment in R&D, and growing awareness of occupational safety and hygiene standards, establishing microbial air samplers as a critical tool across pharmaceutical, clinical, and food production sectors

The U.K. Microbial Air Sampler Market Insight

The U.K. microbial air sampler market is expected to grow at a substantial CAGR during the forecast period, driven by increasing awareness of infection control, hospital hygiene, and contamination prevention in pharmaceutical and food production facilities. The demand for portable and desktop samplers is rising, supported by robust healthcare infrastructure and expanding research activities. Integration with IoT and laboratory information management systems (LIMS) enables centralized monitoring and reporting, which is particularly attractive to large hospitals and academic institutions. Regulatory compliance requirements and growing investments in biotechnology R&D are also stimulating market growth.

Germany Microbial Air Sampler Market Insight

The Germany microbial air sampler market accounted for the largest share in Europe in 2025, driven by stringent cleanroom standards, widespread adoption of advanced laboratory and pharmaceutical technologies, and the presence of leading manufacturers. High investments in biotech, pharmaceutical production, and clinical research are fueling demand for both portable and desktop samplers. Germany’s focus on quality control, innovation, and regulatory adherence ensures continuous adoption of sophisticated air sampling solutions. In addition, integration with real-time monitoring, predictive analytics, and automated reporting systems is becoming prevalent across research and production facilities.

France Microbial Air Sampler Market Insight

The France microbial air sampler market is anticipated to grow at a strong CAGR during the forecast period, fueled by increasing investments in healthcare, pharmaceutical R&D, and food safety initiatives. Hospitals and pharmaceutical companies are adopting microbial air samplers to meet hygiene standards and reduce contamination risks. Portable and real-time samplers are particularly gaining traction due to their flexibility and ability to provide immediate data for rapid decision-making. Government support for biotech research and strict environmental regulations are further contributing to market expansion.

Italy Microbial Air Sampler Market Insight

The Italy microbial air sampler market is poised to grow steadily, driven by rising awareness of cleanroom monitoring in hospitals, research labs, and food & beverage facilities. The adoption of portable and desktop samplers is increasing to ensure compliance with hygiene and safety standards. The country’s growing pharmaceutical and biotechnology sectors, combined with regulatory pressures for product quality and contamination control, are key factors propelling market growth. In addition, demand for real-time and automated air samplers is expected to rise in large manufacturing and research facilities.

Europe Microbial Air Sampler Market Share

The Europe Microbial Air Sampler industry is primarily led by well-established companies, including:

  • MBV AG (Switzerland)
  • Sartorius AG (Germany)
  • BIOMÉRIEUX (France)
  • Merck Millipore (Germany)
  • TSI (U.S.)
  • Climet Instruments Company (U.S.)
  • VWR International, LLC (U.S.)
  • Particle Measuring Systems (U.S.)
  • Bioscience International (U.S.)
  • Aquaria srl (Italy)
  • IUL, S.A. (Spain)
  • MBV (Switzerland)
  • Munro Instruments Limited (U.K.)
  • Cherwell Laboratories (U.K.)
  • Cantium Scientific Limited (U.K.)
  • Orum International Srl (Italy)
  • Awel (France)
  • Sarstedt AG & Co. KG (Germany)
  • Bertin Technologies (France)
  • Advanced Instruments (U.S.)

What are the Recent Developments in Europe Microbial Air Sampler Market?

  • In July 2025, MBV AG launched the MAS‑100 Sirius, a next‑generation active microbial air sampler featuring Wi‑Fi remote operation, automated self‑checks, tamper‑evident data trails, and a world‑first self‑aligning magnetic perforated lid designed to enhance contamination control and data integrity in pharmaceutical cleanrooms
  • In April 2025, Pharmagraph launched the iVAS Roam portable microbial air sampler, expanding its iVAS range with improved compliance (EN 17141:2020), advanced graphical interface, configurable flow rates, and end‑to‑end data integrity features for environmental monitoring in cleanrooms and controlled facilities
  • In July 2024, MBV AG became the exclusive sales partner for Plair’s Rapid‑C+ real‑time air microbial monitor in Germany, Austria, and Switzerland, enabling broader regional distribution of this innovative technology and strengthening links between real‑time detection and traditional sampling methods in Europe
  • In June 2024, Plair SA introduced the Rapid‑C+ real‑time air microbial detector, combining biofluorescent particle counting with traditional active air sampling in a single unit, enabling immediate detection and differentiation of viable contaminants to support GMP Annex 1 compliance and faster environmental monitoring decisions
  • In June 2023, Plair SA showcased its real‑time microbial detection solutions such as the Rapid‑C instrument at the Swiss Cleanroom Community Event, highlighting growing European interest in real‑time bioaerosol monitoring technologies and adoption at specialized industry forums


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The dermatome device market size was valued at USD 226.98 million in 2025.
The dermatome device market is to grow at a CAGR of 5.57% during the forecast period of 2026 to 2033.
The Dermatome Device market is segmented into two notable segments based on type and end-user. On the basis of type, the market is segmented into Drum Dermatome, Air Dermatome, Knife Dermatome, and Powered Dermatome. On the basis of End User, the market is segmented into Hospitals, Ambulatory Surgical Centres, and Specialty Clinics
Companies such as Zimmer Biomet (U.S.), Integra LifeSciences Corporation (U.S.), B. Braun SE (Germany), Aesculap, Inc. (U.S.), Surtex Instruments (U.K.), are major players in dermatome device market.
In February 2025, CUTISS reported positive Phase 2 clinical trial results for denovoSkin™, showing promising outcomes in reconstructive and burn surgery with reduced need for traditional graft harvesting and improved patient recovery. In October 2024, CUTISS AG announced the first ever use of its bio‑engineered denovoSkin™ graft in a compassionate reconstructive surgery in the U.S. for a pediatric burn patient, marking a significant clinical milestone in advanced grafting and reconstructive skin technology
The countries covered in the Dermatome Device market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
The Asia-Pacific is expected to be the fastest growing region in the dermatome device market during the forecast period due to rising healthcare investments, expanding hospital networks, increasing awareness of advanced wound care, and a growing number of reconstructive and cosmetic procedures
The U.S. is expected to dominate the dermatome device market, driven by high prevalence of burn injuries and reconstructive surgeries

Industry Related Reports

Testimonial